Abstract
Ecstasy (methylenedioxymethamphetamine, MDMA) is a synthetic drug which is popular among clubbers who love it for its euphoric and energizing effects. These subjective effects are experienced approximately between one and four hours after intake. It is also shown that MDMA affects driving-related behavior, as measured by performance tasks and simulated driving, as well as actual driving as assessed by on-the-road driving tests. Under optimal conditions that are during daytime, moderate doses, and with no co-use of other substances MDMA exerts stimulating effects on reaction time performance, tracking and weaving. However, when MDMA is combined with alcohol or sleep deprivation, these stimulating effects are no longer observable. Combined use of MDMA with cannabis or alcohol is common among ecstasy users. In addition, they usually take the drug at night and drive in the morning after a night of partying and sleep loss. Experimental data have shown that the stimulating effects of MDMA are not of sufficient magnitude to compensate for the impairing effects of sleep loss. Moreover, subjective data have shown that ecstasy users are not able to accurately estimate their objective impairment when under the influence of MDMA. Their lack of judgment during intoxication can put them at risk when engaged in traffic. Epidemiological studies and case studies have also shown that MDMA at normal doses (75 mg) is able to impair driving performance which is characterized by reckless behavior such as speeding and jumping red traffic lights. In addition, in a number of fatalities, ecstasy was detected in the blood of the driver. In sum, MDMA can exert stimulating effects on some aspects of driving when given at low doses. However MDMA is likely to produce driving impairment in combination with other drugs or during a night of sleep loss as is often the case in regular ecstasy users.
Chapter PDF
References
ter Bogt TFM, Engels RCME (2005) “Partying” hard: party style, motives for and effects of MDMA use at rave parties. Subst Use Misuse 40: 1479–1502
Milroy CM (1999) Ten years of “ecstasy”. J R Soc Med 92: 68–71
Furr Holden D, Voas RB, Kelley Baker T, Miller B (2006) Drug and alcohol-impaired driving among electronic music dance event attendees. Drug Alcohol Depend 85: 83–86
Riley SCE, Hayward E (2004) Patterns, trends, and meanings of drug use by dance-drug users in Edinburgh, Scotland. Drugs: Education, Prevention and Policy 11: 243–262
5 EWDD (2007) Jaarverslag 2007. Stand van de drugsproblematiek in Europa. In: EWvDe Drugsverslaving (ed). Bureau voor officiele publicaties der Europese Gemeenschappen, Luxemburg
McCambridge J, Mitcheson L, Winstock A, Hunt N (2005) Five-year trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom. Addiction 100: 1140–1149
Franken IH (2001) Prevalence of MDMA (ecstasy) use and neurotoxicity. Eur Psychiatry 16: 508–509
Riley SC, James C, Gregory D, Dingle H, Cadger M (2001) Patterns of recreational drug use at dance events in Edinburgh, Scotland. Addiction 96: 1035–1047
van de Wijngaart GF, Braam R, de Bruin D, Fris M, Maalste NJM, Verbraeck HT (1999) Ecstasy use at large-scale dance events in the Netherlands. Journal of Drug Issues 29: 679–702
Barrett SP, Gross SR, Garand I, Pihl RO (2005) Patterns of Simultaneous Polysubstance Use in Canadian Rave Attendees. Subst Use Misuse 40: 1525–1537
Topp L, Hando J, Dillon P, Roche A, Solowij N (1999) Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend 55: 105–115
Winstock AR, Griffiths P, Stewart D (2001) Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug Alcohol Depend 64: 9–17
Hausken AM, Skurtveit S, Christophersen AS (2004) Characteristics of drivers testing positive for heroin or ecstasy in Norway. Traffic Injury Prevention 5: 107–111
Duff C, Rowland B (2006) “Rushing behind the wheel”: Investigating the prevalence of “drug driving” among club and rave patrons in Melbourne, Australia. Drugs: Education, Prevention and Policy 13: 299–312
Logan BK, Couper FJ (2001) 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment. J Forensic Sci 46: 1426–1433
Logan BK, Couper FJ (2003) 3.4-Methylenedioxymethamphetamine-effects on human performance and behavior. Forensic Sci Rev 15: 12–28
Schifano F (1995) Dangerous driving and MDMA (“Ecstasy”) abuse. Journal of Serotonin Research 1: 53–57
Bost RO (1988) 3,4-Methylenedioxymethamphetamine (MDMA) and other amphetamine derivatives. J Forensic Sci 33: 576–587
del Rio CM, Gomez J, Sancho M, Alvarez FJ (2002) Alcohol, illicit drugs and medicinal drugs in fatally injured drivers in Spain between 1991 and 2000. Forensic Sci Int 127:63–70
Drummer OH, Gerostamoulos J, Batziris H, Chu M, Caplehorn J, Robertson MD, Swann P (2004) The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accid Anal Prev 36: 239–248
Hall AP, Henry JA (2006) Acute toxic effects of “Ecstasy” (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth 96: 678–685
Kalant H (2001) The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs. CMAJ 165: 917–928
Brookhuis KA, de Vries G, de Waard D (1991) The effects of mobile telephoning on driving performance. Accid Anal Prev 23: 309–316
Al-Shihabi T, Mourant, R.R. (2001) A framework for modeling human-like driving behaviors for autonomous vehicles in driving simulators: Fifth international conference on Autonomous agents. ACM New York, NY, USA, Montreal, Canada, 286–291
Janssen WH (1979) Routeplanning en geleiding: Een literatuurstudie: Report IZF 1979 V.13. Institute for perception TNO, Soesterberg, The Netherlands
Lamers CT, Ramaekers JG, Muntjewerff ND, Sikkema KL, Samyn N, Read NL, Brookhuis KA, Riedel WJ (2003) Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance. J Psychopharmacol 17: 379–387
Kuypers KPC, Samyn N, Ramaekers JG (2006) MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function. Psychopharmacology 187: 467–475
Kuypers KPC, Wingen M, Limbert N, Samyn N, Ramaekers JG (2007) Acute effects of nocturnal doses of MDMA on measures of impulsivity and psychomotor performance throughout the night. Psychopharmacology (Berl) 192: 111–119
Parrott AC, Lees A, Garnham NJ, Jones M, Wesnes K (1998) Cognitive performance in recreational users of MDMA of “ecstasy”: evidence for memory deficits. J Psychopharmacol 12: 79–83
Kuypers KPC, Ramaekers JG (2007) Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected. Psychopharmacology (Berl) 189: 557–563
Parrot AC, Lasky (1998) Ecstasy (MDMA) effects upon mood and cognition: before, during and after a saturday night dance. Psychopharmacology (Berl.) 139: 261–268
Vollenweider FX, Gamma A, Liechti M, Huber T (1998) Psychological and cardiovascular effects and short-term sequelae of MDMA (“ecstasy”) in MDMA-naive healthy volunteers. Neuropsychopharmacology 19: 241–251
Ramaekers JG, Kuypers KPC (2006) Acute Effects of 3,4-Methylenedioxymethamphetamine (MDMA) on Behavioral Measures of Impulsivity: Alone and in Combination with Alcohol. Neuropsychopharmacology 31: 1048–1055
Downing J (1986) The psychological and physiological effects of MDMA on normal volunteers. J Psychoactive Drugs 18: 335–340
Ramaekers JG, Kuypers KPC, Samyn N (2006) Stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal. Addiction 101: 1614–1621
Kuypers KPC, Ramaekers JG (2005) Transient memory impairment after acute dose of 75mg 3.4-Methylene-dioxymethamphetamine. J Psychopharmacol 19: 633–639
Hernandez Lopez C, Farre M, Roset PN, Menoyo E, Pizarro N, Ortuno J, Torrens M, Cami J, de La Torre R (2002) 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics. J Pharmacol Exp Ther 300: 236–244
Cami J, Farre M, Mas M, Roset PN, Poudevida S, Mas A, San L, de la Torre R (2000) Human pharmacology of 3,4-methylenedioxymethamphetamine (“ecstasy”): psychomotor performance and subjective effects. J Clin Psychopharmacol 20: 455–466
Brookhuis KA, De Waard D, Samyn N (2004) Effects of MDMA (ecstasy), and multiple drugs use on (simulated) driving performance and traffic safety. Psychopharmacology (Berl) 173: 440–445
O’Hanlon JF (1984) Driving performance under the influence of drugs: rationale for, and application of, a new test. Br J Clin Pharmacol 18 Suppl 1: 121s–129s
Ramaekers JG, Robbe HWJ, O’Hanlon JF (2000) Marijuana, alcohol and actual driving performance. Human Psychopharmacology Clinical and Experimental 15: 551–558
Neale J (2001) Driving on recreational drugs: A qualitative investigation of experiences from behind the wheel. Drugs: Education, Prevention and Policy 8: 315–325
de Almeida SP, Silva MT (2003) Ecstasy (MDMA): effects and patterns of use reported by users in Sao Paulo. Rev Bras Psiquiatr 25: 11–17
Parrott AC (2001) Human psychopharmacology of Ecstasy (MDMA): A review of 15 years of empirical research. Human Psychopharmacology Clinical and Experimental 16: 557–577
Parrott AC (2005) Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy. J Psychopharmacol 19: 71–83
de la Torre R, Farre M, Ortuno J, Mas M, Brenneisen R, Roset PN, Segura J, Cami J (2000) Non-linear pharmacokinetics of MDMA (’ecstasy’) in humans. Br J Clin Pharmacol 49: 104–109
47 DIMS (2005) DIMS Jaarbericht 2005. Trimbos institute Netherlands Institute of Mental health and Addiction, 1–4
Kuypers KPC, Wingen M, Ramaekers JG (2008) Memory and mood during the night and in the morning after repeated evening doses of MDMA. J Psychopharmacol In press
Dawson D, Reid K (1997) Fatigue, alcohol and performance impairment. Nature 388: 235
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Birkhäuser Verlag/Switzerland
About this chapter
Cite this chapter
Kuypers, K.P., Bosker, W.M., Ramaekers, J.G. (2009). Ecstasy, driving and traffic safety. In: Verster, J.C., Pandi-Perumal, S.R., Ramaekers, J.G., de Gier, J.J. (eds) Drugs, Driving and Traffic Safety. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-9923-8_30
Download citation
DOI: https://doi.org/10.1007/978-3-7643-9923-8_30
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-9922-1
Online ISBN: 978-3-7643-9923-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)